GLR
AZN icon

Great Lakes Retirement’s AstraZeneca AZN Stock Holding History

Great Lakes Retirement’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Sell
13,247
-62
-0.5% -$11.7K 0.22% 91
2026
Q1 		$2.62M Buy
+13,309
New +$2.57M 0.27% 81
2024
Q3 		– Sell
-56
Closed -$8.73K – 233
2024
Q2 		$8.73K Buy
+56
New +$8.43K ﹤0.01% 490

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Great Lakes Retirement's AZN Position: Q2 2026 in Review

Great Lakes Retirement reduced its AstraZeneca (AZN) stake by 0.47% in Q2 2026, selling an estimated $11.7K and leaving 13,247 shares worth $2.51M. The position accounts for 0.22% of the portfolio, ranked #91.

Great Lakes Retirement first reported a position in AZN in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.62M in Q1 2026. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Great Lakes Retirement held 13,247 shares of AstraZeneca worth $2.51M as of Q2 2026.
  • Great Lakes Retirement sold 62 AstraZeneca shares in Q2 2026, an estimated $11.7K.
  • AstraZeneca made up 0.22% of Great Lakes Retirement's portfolio in Q2 2026, its #91 holding.
  • Great Lakes Retirement first reported a position in AstraZeneca in Q2 2024 and has held it in 3 quarters since.
  • Great Lakes Retirement's AstraZeneca position peaked at $2.62M in Q1 2026.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Great Lakes Retirement's 13F filing for Q2 2026, filed 30 Jul 2026.